These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11060768)

  • 41. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Corticosteroids in sepsis: a new concept for an old drug.
    Klaitman V; Almog Y
    Isr Med Assoc J; 2003 Jan; 5(1):51-5. PubMed ID: 12592960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroids in sepsis--more effective than activated protein C?
    Bradley C
    Intensive Crit Care Nurs; 2001 Aug; 17(4):242-4. PubMed ID: 11868733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose.
    Minneci PC; Deans KJ; Banks SM; Eichacker PQ; Natanson C
    Ann Intern Med; 2004 Jul; 141(1):47-56. PubMed ID: 15238370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunomodulatory therapies in sepsis.
    Kox WJ; Volk T; Kox SN; Volk HD
    Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of glucocorticoids as adjunctive treatment for sepsis in the modern era.
    Marik PE
    Lancet Respir Med; 2018 Oct; 6(10):793-800. PubMed ID: 30006071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rat in sepsis and endotoxic shock.
    Wise WC; Cook JA; Tempel GE; Reines HD; Halushka PV
    Prog Clin Biol Res; 1989; 299():243-52. PubMed ID: 2657793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Melatonin in septic shock: some recent concepts.
    Srinivasan V; Pandi-Perumal SR; Spence DW; Kato H; Cardinali DP
    J Crit Care; 2010 Dec; 25(4):656.e1-6. PubMed ID: 20435434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corticosteroids for septic shock.
    Annane D
    Crit Care Med; 2001 Jul; 29(7 Suppl):S117-20. PubMed ID: 11445745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
    Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
    Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists.
    Ketteler M; Cetto C; Kirdorf M; Jeschke GS; Schäfer JH; Distler A
    Kidney Int Suppl; 1998 Feb; 64():S27-30. PubMed ID: 9475485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of sepsis: past and future avenues.
    Baumgartner JD; Calandra T
    Drugs; 1999 Feb; 57(2):127-32. PubMed ID: 10188756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokine modulation in sepsis and septic shock.
    Zanotti S; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1061-75. PubMed ID: 12150702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy.
    Vazquez-Grande G; Kumar A
    Semin Respir Crit Care Med; 2015 Feb; 36(1):154-66. PubMed ID: 25643278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replacement therapy with hydrocortisone in catecholamine-dependent septic shock.
    Annane D
    J Endotoxin Res; 2001; 7(4):305-9. PubMed ID: 11717587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
    Wu A; Hinds CJ; Thiemermann C
    Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Future perspectives on regulating pro-and anti-inflammatory responses in sepsis.
    Delsesto D; Opal SM
    Contrib Microbiol; 2011; 17():137-156. PubMed ID: 21659751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.